Product approvals

August 30, 2017 - 11:27 am
WASHINGTON (AP) — Opening a new era in cancer care, the Food and Drug Administration on Wednesday approved the first treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia. The CAR-T cell treatment developed by Novartis and...
Read More
FILE - This Thursday, Dec.18, 2014, file photograph, shows the Merck logo on a stained glass panel at a Merck company building in Kenilworth, N.J. A new type of cholesterol drug meant to prevent heart attacks and other complications clearly did so, in an unusually large study whose results were announced Tuesday, Aug. 29, 2017, at a conference of heart specialists. But the daily pill only reduced those complications by 9 percent, leaving drugmaker Merck with a tough call on whether to seek regulatory approval after spending 13 years and likely hundreds of millions of dollars on testing. (AP Photo/Mel Evans, File)
August 29, 2017 - 2:35 am
TRENTON, N.J. (AP) — So-so results for a new type of cholesterol drug have left Merck in a quandary: Does the company try to bring it to market or scrap it? A large, long-term study of the drug showed that it prevents heart attacks and reduces the need for heart procedures, while three similar...
Read More
FILE - This Sept. 21, 2010 file photo shows the interior of the lethal injection facility at San Quentin State Prison in San Quentin, Calif. The California Supreme Court upheld a ballot measure narrowly approved by voters to change the state's dysfunctional death penalty system and speed up executions. The highly anticipated ruling Thursday, Aug. 24, 2017 concerned Proposition 66, a push to "mend not end" capital punishment in California. (AP Photo/Eric Risberg, File)
August 25, 2017 - 9:08 pm
SAN FRANCISCO (AP) — California correctional officials on Friday asked state regulators to approve a revised method of carrying out death sentences after years of delays that have stalled executions since 2006. The new regulations would allow California's death row inmates to be executed using one...
Read More
FILE - In this Monday, Nov. 23, 2015, file photo, a Pfizer flag is displayed in front of the company's world headquarters in New York. The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed. Pfizer’s Besponsa was approved for patients with a type of advanced acute lymphoblastic leukemia. (AP Photo/Mark Lennihan, File)
August 17, 2017 - 5:35 pm
TRENTON, N.J. (AP) — The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed. The agency approved Pfizer Inc.'s Besponsa for patients with a type of advanced acute lymphoblastic leukemia. By then, life...
Read More
FILE- In this Saturday, July 1, 2017, file photo, people line up at the NuLeaf marijuana dispensary in Las Vegas. The Nevada Tax Commission is expected to approve an emergency regulation on Thursday, July 13, to issue distribution licenses needed to address an anticipated supply shortage in the coming weeks. (AP Photo/John Locher, File)
July 13, 2017 - 9:22 pm
CARSON CITY, Nev. (AP) — Nevada moved Thursday to reduce supply problems at recreational marijuana stores that have faced overwhelming demand for newly legal pot and the possibility of their shelves going empty. Regulators approved emergency rules that would speed up licensing for pot distributors...
Read More
FILE- In this Saturday, July 1, 2017, file photo, people line up at the NuLeaf marijuana dispensary in Las Vegas. The Nevada Tax Commission is expected to approve an emergency regulation on Thursday, July 13, to issue distribution licenses needed to address an anticipated supply shortage in the coming weeks. (AP Photo/John Locher, File)
July 13, 2017 - 8:30 pm
CARSON CITY, Nev. (AP) — Nevada moved Thursday to reduce supply problems at recreational marijuana stores that have faced overwhelming demand for newly legal pot and the possibility of their shelves going empty. Regulators approved emergency rules that would speed up licensing for pot distributors...
Read More
June 15, 2017 - 4:28 pm
U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical greed. The Food and Drug Administration on Thursday approved Adamis (ad-DEHM-iss) Pharmaceuticals Corp.'s product, which should go on sale later this year...
Read More
This image provided by Novartis shows Rydapt. The Food and Drug Administration on Friday approved Rydapt for treating adults newly diagnosed with acute myeloid leukemia who have a genetic mutation called FLT3. Patients would take it along with chemotherapy. The drug, known chemically as midostaurin, is the first new medicine for acute myeloid leukemia in 25 years, according to the company. (Novartis via AP)
April 28, 2017 - 4:13 pm
U.S. regulators have approved the first targeted drug for certain patients with an aggressive form of leukemia. The Food and Drug Administration on Friday approved the drug for adults with acute myeloid leukemia who have a genetic mutation called FLT3. Also OK'd was a test to identify those...
Read More
FILE - This Wednesday, Oct. 14, 2015, file photo shows the U.S. Food and Drug Administration campus, in Silver Spring, Md. The FDA is warning consumers to avoid 65 bogus products hawked on the internet with false claims that they can cure, treat or prevent cancer. (AP Photo/Andrew Harnik, File)
April 25, 2017 - 2:44 pm
TRENTON, N.J. (AP) — U.S. regulators are warning consumers to avoid 65 bogus products hawked on the internet with false claims that they can cure, treat, diagnose or prevent cancer. The Food and Drug Administration says these products , mostly sold on websites and social media sites, can be harmful...
Read More
April 25, 2017 - 1:06 pm
U.S. regulators are warning consumers to avoid 65 bogus products hawked on the internet with false claims that they can cure, treat or prevent cancer. The Food and Drug Administration says these products , mostly sold on websites and social media, can be harmful, waste money and result in people...
Read More

Pages